510(k) K252296
K252296 is an FDA 510(k) premarket notification submitted by Oncopatch, Inc. for the device "OncoPatch". The FDA issued a decision of Substantially Equivalent on Dec 5, 2025. The device falls under product code KXK (Source, Brachytherapy, Radionuclide), a Class II device regulated under 21 CFR 892.5730.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 5, 2025
- Date Received
- Jul 23, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Source, Brachytherapy, Radionuclide
- Device Class
- Class II
- Regulation Number
- 892.5730
- Review Panel
- RA
- Submission Type
- 510(k)
Need the full FDA record for Oncopatch, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.